bullish

Fancl Corp

Fancl (4921 JP):  Worth A Bet Given Negative Impact Of Kobayashi Products Recall Subsiding

859 Views22 May 2024 10:57
With the nutritional supplements overhang removed, I believe the stock price is attractive at 23x 2024 PE with 15% expected earnings CAGR for the next 3 years.
What is covered in the Full Insight:
  • Overview of Fancl Corp's Financial Performance
  • Download On Share Price and Market Performance
  • Business Segments and Sales Breakdown
  • International Growth Prospects
  • Margin Improvement and Projections
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 2-minute read)
Discussions
(Paid Plans Only)
chart-bar
Price Chart(Sign Up to Access)
analytics-chart
  • Fancl (4921 JP):  Worth A Bet Given Negative Impact Of Kobayashi Products Recall Subsiding
    22 May 2024
x